Altering phosphorylation of dystrophin S3059 to attenuate cancer cachexia
Strategies to increase phosphorylation of this site, and/or increase dystrophin protein expression, have therapeutic potential for cancer cachexia.
Authors
- Paul Gregorevic (ORCID: https://orcid.org/0000-0002-7418-8945)
- Gordon S. Lynch (ORCID: https://orcid.org/0000-0001-9220-9810)
- Justin P. Hardee (ORCID: https://orcid.org/0000-0001-6469-9592)
- Christopher J. Brock
- Kate T. Murphy (ORCID: https://orcid.org/0000-0003-1993-4367)
- Andrew J. Kueh (ORCID: https://orcid.org/0009-0005-9596-1422)
- Annabel Chee
- Jennifer Trieu (ORCID: https://orcid.org/0000-0003-0016-0998)
- Wenlan Li (ORCID: https://orcid.org/0000-0003-0136-1070)
- Audrey Chan (ORCID: https://orcid.org/0000-0002-9417-0718)
- Kristy Swiderski (ORCID: https://orcid.org/0000-0002-2509-4619)
- Dale M. Baum
- Timur Naim (ORCID: https://orcid.org/0009-0007-3987-2841)
- Marco J. Herold (ORCID: https://orcid.org/0000-0001-7539-7581)
Institutions
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Olivia Newton-John Cancer Wellness & Research Centre (AU)
Publication Details
- Journal
- Life Sciences
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1016/j.lfs.2024.123343
- Citations
- 3
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.70